Synergistic nisin-polymyxin combinations for the control of Pseudomonas biofilm formation
Cotter, Paul D.
Ross, R. Paul
The emergence and dissemination of multi-drug resistant pathogens is a global concern. Moreover, even greater levels of resistance are conferred on bacteria when in the form of biofilms (i.e., complex, sessile communities of bacteria embedded in an organic polymer matrix). For decades, antimicrobial peptides have been hailed as a potential solution to the paucity of novel antibiotics, either as natural inhibitors that can be used alone or in formulations with synergistically acting antibiotics. Here, we evaluate the potential of the antimicrobial peptide nisin to increase the efficacy of the antibiotics polymyxin and colistin, with a particular focus on their application to prevent biofilm formation of Pseudomonas aeruginosa. The results reveal that the concentrations of polymyxins that are required to effectively inhibit biofilm formation can be dramatically reduced when combined with nisin, thereby enhancing efficacy, and ultimately, restoring sensitivity. Such combination therapy may yield added benefits by virtue of reducing polymyxin toxicity through the administration of significantly lower levels of polymyxin antibiotics.
Biofilm , Colistin , Polymyxin , Nisin , Lantibiotic , P. aeruginosa , Bacteriocin , Antibiotics
Field, D., Seisling, N., Cotter, P. D., Ross, R. P. and Hill, C. (2016) ‘Synergistic nisin-polymyxin combinations for the control of Pseudomonas biofilm formation. Frontiers in Microbiology, 7, 1713 (7pp). doi: 10.3389/fmicb.2016.01713
© 2016 Field, Seisling, Cotter, Ross and Hill. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.